Julia Barczuk

6PUBLICATIONS
9CO-AUTHORS
Medical infection agents (incl. prions)Neurology and neuromuscular diseasesMolecular targetsPredictive and prognostic markersVision science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 09, 2024
Noradrenaline Protects Human Microglial Cells (HMC3) Against Apoptosis and DNA Damage Induced by LPS and Aβ1-42 Aggregates In Vitro.

Julia Barczuk, Grzegorz Galita, Natalia Siwecka

|Oct 16, 2024
Potential Mechanisms of Tunneling Nanotube Formation and Their Role in Pathology Spread in Alzheimer's Disease and Other Proteinopathies.

Szymon Kotarba, Marta Kozłowska, Małgorzata Scios

|Sep 28, 2024
SEPT9_i1 and Septin Dynamics in Oncogenesis and Cancer Treatment.

Piotr Jędrzejczak, Kamil Saramowicz, Justyna Kuś

|Apr 27, 2024
NCI 159456 PERK Inhibitor as a Targeted Therapy for Lung Cancer: An In Vitro Study.

Wioletta Rozpędek-Kamińska, Grzegorz Galita, Natalia Siwecka

|Jan 23, 2024
Evaluation of the LDN-0060609 PERK Inhibitor as a Selective Treatment for Primary Open-Angle Glaucoma: An In Vitro Study on Human Retinal Astrocytes.

Wioletta Rozpędek-Kamińska, Grzegorz Galita, Kamil Saramowicz

|Nov 14, 2023
PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies-New Therapeutic Possibilities.

Wojciech Wiese, Julia Barczuk, Olga Racinska

Pageof 1